• Abstract
• Full-Text PDF [183 KB]
• Full-Text XML
• Article Versions Notes
• Supplement File 1

• Article Statistics
• PubMed/Medline
• Google Scholar
• Order Reprints

• Cite this article
• Export to BibTeX
• Export to EndNote

• [+] on DOAJ
• Pimentel-Elardo, S
• Kozytska, S
• Bugni, T
• Ireland, C
• Moll, H
• Hentschel, U
• [+] on Google Scholar
• Pimentel-Elardo, S
• Kozytska, S
• Bugni, T
• Ireland, C
• Moll, H
• Hentschel, U
• [+] on PubMed
• Pimentel-Elardo, S
• Kozytska, S
• Bugni, T
• Ireland, C
• Moll, H
• Hentschel, U

•  CiteULike
•  Facebook
•  Mendeley
•  Twitter

This article is

• freely available
• re-usable

Mar. Drugs 2010, 8(2), 373-380; doi:10.3390/md8020373

Communication

Anti-Parasitic Compounds from Streptomyces sp. Strains Isolated from Mediterranean Sponges

Sheila Marie Pimentel-Elardo ^1,2,* , Svitlana Kozytska ² , Tim S. Bugni ^3,† , Chris M. Ireland ³ , Heidrun Moll ²  and Ute Hentschel ^1,2

¹ Julius-von-Sachs Institute for Biological Sciences, University of Würzburg, Julius-von-Sachs Platz 3, 97082 Würzburg, Germany ² Research Center for Infectious Diseases, Josef-Schneider-Straße 2, 97080 Würzburg, Germany ³ Department of Medicinal Chemistry, University of Utah, Salt Lake City, 84112 Utah, USA ^† Present address: School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705, USA.

* Author to whom correspondence should be addressed.

Received: 26 December 2009; in revised form: 2 February 2010 / Accepted: 4 February 2010 / Published: 23 February 2010

(This article belongs to the Special Issue Marine Anti-infective Agents)

Download PDF Full-Text [183 KB, uploaded 23 February 2010 15:02 CET]

Abstract: Actinomycetes are prolific producers of pharmacologically important compounds accounting for about 70% of the naturally derived antibiotics that are currently in clinical use. In this study, we report on the isolation of Streptomyces sp. strains from Mediterranean sponges, on their secondary metabolite production and on their screening for anti-infective activities. Bioassay-guided isolation and purification yielded three previously known compounds namely, cyclic depsipeptide valinomycin, indolocarbazole alkaloid staurosporine and butenolide. This is the first report of the isolation of valinomycin from a marine source. These compounds exhibited novel anti-parasitic activities specifically against Leishmania major (valinomycin IC₅₀ < 0.11 µM; staurosporine IC₅₀ 5.30 µM) and Trypanosoma brucei brucei (valinomycin IC₅₀ 0.0032 µM; staurosporine IC₅₀ 0.022 µM; butenolide IC₅₀ 31.77 µM). These results underscore the potential of marine actinomycetes to produce bioactive compounds as well as the re-evaluation of previously known compounds for novel anti-infective activities.

Keywords: marine sponges; Streptomyces; valinomycin; staurosporine; butenolide; anti-parasitic

Supplementary Files

• Supplementary File 1:

  PDF-Document (PDF, 53 KB)

Article Statistics

Cite This Article